Steffen Wagner is the founder of Advanz Pharma. Backed by Nordic Capital. Based in London, United Kingdom.
Steffen Wagner is the CEO of Advanz Pharma, a global pharmaceutical company focusing on specialty hospitals and rare disease pharmaceuticals. Nordic Capital acquired Advanz Pharma in 2021, and since then, the company has seen increased revenues and expanded its expertise in therapeutic areas such as critical care, anti-infectives, endocrinology, and cardiovascular. Under Wagner's leadership, Advanz Pharma has pursued M&A, including acquiring Intercept Pharmaceutical's subsidiaries outside the US and extending a partnership with Alvotech for biosimilars.
Full founder directory · Investor directory · Company funding database · Fundraising library